Zom RL 1 , van Baal J, Goselink RM, Bakker JA, de Veth MJ, van Vuuren AM
GLP3 peptide was engineered from a GIP peptide backbone to simultaneously activate GLP-1, GIP, and glucagon receptors, while Cagrilintide peptide is a modified amylin analog designed with enhanced stability to resist the fibrillation that makes native amylin challenging to work with
Keep out of reach of children and pets
This is the pharmacological basis for CagriSema : in REDEFINE 1, the combination produced 20.4% mean weight loss versus 11.8% for cagrilintide alone and 14.9% for semaglutide alone
It is often called the master antioxidant because it is produced naturally within your cells
Dahabiyeh LA, Mahmoud NN, Al-Natour MA, Safo L, Kim D-H, Khalil EA